<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="aved" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">aved</book-part-id>
      <title-group>
        <title>Ataxia with Vitamin E Deficiency</title>
        <alt-title alt-title-type="alt-title">Synonyms: Ataxia with Isolated Vitamin E Deficiency, AVED, Familial Isolated Vitamin E Deficiency, Friedreich-Like Ataxia</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Schuelke</surname>
            <given-names>Markus</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Neuropediatrics <break/>Charit&#x000e9; &#x00026; NeuroCure Clinical Research Center<break/>Charit&#x000e9; - Universit&#x000e4;tsmedizin Berlin<break/>Berlin, Germany</aff>
          <email>markus.schuelke@charite.de</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>20</day>
          <month>5</month>
          <year>2005</year>
        </date>
        <date date-type="updated">
          <day>13</day>
          <month>10</month>
          <year>2016</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="aoa2" document-type="chapter">Ataxia with Oculomotor Apraxia Type 2</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="ataxia-telangiectas" document-type="chapter">Ataxia-Telangiectasia</related-object>
      <abstract id="aved.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Ataxia with vitamin E deficiency (AVED) generally manifests in late childhood or early teens between ages five and 15 years. The first symptoms include progressive ataxia, clumsiness of the hands, loss of proprioception, and areflexia. Other features often observed are dysdiadochokinesia, dysarthria, positive Romberg sign, head titubation, decreased visual acuity, and positive Babinski sign. The phenotype and disease severity vary widely among families with different pathogenic variants; age of onset and disease course are more uniform within a given family, but symptoms and disease severity can vary even among sibs.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Presently, no consensus diagnostic criteria for AVED exist; the principal criterion for diagnosis is a Friedreich ataxia-like neurologic phenotype combined with markedly reduced plasma vitamin E (&#x003b1;-tocopherol) concentration and a normal lipoprotein profile in the absence of known causes of malabsorption. Identification of biallelic <italic toggle="yes">TTPA</italic> pathogenic variants on molecular genetic testing confirms the diagnosis.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: Lifelong high-dose oral vitamin E supplementation to bring plasma vitamin E concentrations into the high-normal range; treatment early in the disease process may to some extent reverse ataxia and mental deterioration.</p>
          <p><italic toggle="yes">Prevention of primary manifestations</italic>: Vitamin E therapy in presymptomatic children with biallelic <italic toggle="yes">TTPA</italic> pathogenic variants prevents development of symptoms.</p>
          <p><italic toggle="yes">Surveillance:</italic> Monitor plasma vitamin E concentration every six months, particularly in children.</p>
          <p><italic toggle="yes">Agents/circumstances to</italic>
<italic toggle="yes">avoid</italic>: Smoking; occupations requiring quick responses or good balance.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk</italic>: Evaluation for vitamin E deficiency, especially in younger sibs of a proband.</p>
          <p><italic toggle="yes">Other</italic>: Before attempting to drive a car, assessment to determine if the affected individual can drive safely.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>AVED is inherited in an autosomal recessive manner. The parents of an affected child are obligate heterozygotes and carry one pathogenic variant; heterozygotes are asymptomatic. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier detection for at-risk family members and prenatal diagnosis for pregnancies at increased risk are possible if the pathogenic variants in the family have been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="aved.Diagnosis">
        <title>Diagnosis</title>
        <sec id="aved.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Ataxia with vitamin E deficiency (AVED) <bold>should be suspected</bold> in individuals who typically present at the beginning of puberty with the following:</p>
          <p>
            <bold>Clinical features</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Progressive ataxia</p>
            </list-item>
            <list-item>
              <p>Clumsiness of the hands</p>
            </list-item>
            <list-item>
              <p>Loss of proprioception (especially distal joint position and vibration sense)</p>
            </list-item>
            <list-item>
              <p>Areflexia</p>
            </list-item>
            <list-item>
              <p>Dysdiadochokinesia</p>
            </list-item>
            <list-item>
              <p>Positive Romberg sign</p>
            </list-item>
            <list-item>
              <p>Head titubation</p>
            </list-item>
            <list-item>
              <p>Decreased visual acuity</p>
            </list-item>
            <list-item>
              <p>Positive Babinski sign</p>
            </list-item>
            <list-item>
              <p>Macular atrophy, retinitis pigmentosa</p>
            </list-item>
          </list>
          <p>
            <bold>Laboratory findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Normal lipid and lipoprotein profile</p>
            </list-item>
            <list-item>
              <p>Very low plasma vitamin E (&#x003b1;-tocopherol) concentration</p>
              <p>Note: (1) There is no universal normal range of plasma vitamin E concentration, as it depends on the test method and varies among laboratories. In <xref ref-type="bibr" rid="aved.REF.finckh.1995.210">Finckh et al [1995]</xref>, the normal range lies between 9.0 and 29.8 &#x000b5;mol/L (mean &#x000b1; 2 SD). In <xref ref-type="bibr" rid="aved.REF.el_euchfayache.2014.402">El Euch-Fayache et al [2014]</xref> the normal range is given as 16.3-34.9 &#x000b5;mol/L, while individuals with AVED had vitamin E levels between 0.00 and 3.76 &#x000b5;mol/L (mean 0.95 &#x000b5;mol/L, SD 1.79 &#x000b5;mol/L; n=132). In individuals with AVED, the plasma vitamin E concentration is generally lower than 4.0 &#x000b5;mol/L (&#x0003c;1.7 mg/L) [<xref ref-type="bibr" rid="aved.REF.cavalier.1998.301">Cavalier et al 1998</xref>, <xref ref-type="bibr" rid="aved.REF.mariotti.2004.130">Mariotti et al 2004</xref>]. (2) Because oxidation of &#x003b1;-tocopherol by air may invalidate test results, the following precautions should be taken:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Centrifugation of the EDTA blood soon after venipuncture</p>
                </list-item>
                <list-item>
                  <p>Quick separation of plasma from blood cells after centrifugation and subsequent flash freezing of the plasma in liquid nitrogen</p>
                </list-item>
                <list-item>
                  <p>Filling the space above the plasma with an inert gas (e.g., argon or nitrogen)</p>
                </list-item>
                <list-item>
                  <p>Protecting the sample from light by wrapping the container in aluminum foil, or using a black or light-shielded Eppendorf tube</p>
                </list-item>
                <list-item>
                  <p>Shipment of the sample to the test laboratory in dry ice</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>
            <bold>Electrophysiologic findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>In a large study of 132 individuals with AVED from North Africa, 45 individuals were investigated neurophysiologically (e.g., median and peroneal nerve motor conduction velocity, compound muscle action potential, median and saphenous nerve sensory action potential, and sensory action potential) [<xref ref-type="bibr" rid="aved.REF.el_euchfayache.2014.402">El Euch-Fayache et al 2014</xref>].</p>
              <list list-type="bullet">
                <list-item>
                  <p>9% had normal findings.</p>
                </list-item>
                <list-item>
                  <p>47% had mild neuropathy (at least 1 parameter 70%-100% of lower limit of normal [LLN]).</p>
                </list-item>
                <list-item>
                  <p>27% had moderate neuropathy (at least 1 parameter 30%-70% of LLN).</p>
                </list-item>
                <list-item>
                  <p>17% had severe neuropathy (at least 1 parameter &#x0003c;30% of LLN or no response).</p>
                </list-item>
                <list-item>
                  <p>Neuropathy was either purely sensory (34%), purely motor (24%), or combined (42%).</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Somatosensory evoked potentials show increased central conduction time between the segment C1 (N13b) and the sensorimotor cortex (N20), increased latencies of the N20 (median nerve) and P40 (tibial nerve) waves. The P40 wave may be missing completely [<xref ref-type="bibr" rid="aved.REF.schuelke.1999.240">Schuelke et al 1999</xref>].</p>
            </list-item>
          </list>
          <p>Note: No electrophysiologic findings are specific to or diagnostic of AVED; even a severe neuropathy does not exclude AVED.</p>
          <p>
            <bold>Neuroimaging</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Cerebellar atrophy [<xref ref-type="bibr" rid="aved.REF.mariotti.2004.130">Mariotti et al 2004</xref>]; present in approximately half of reported individuals</p>
            </list-item>
            <list-item>
              <p>Small T<sub>2</sub> high-intensity spots in the periventricular region and the deep white matter [<xref ref-type="bibr" rid="aved.REF.usuki.2000.254">Usuki &#x00026; Maruyama 2000</xref>]; inconsistent finding in some individuals</p>
            </list-item>
          </list>
          <p>Note: No radiologic findings are specific to or diagnostic of AVED.</p>
          <p><bold>Histopathology findings</bold> [<xref ref-type="bibr" rid="aved.REF.larnaout.1997.633">Larnaout et al 1997</xref>, <xref ref-type="bibr" rid="aved.REF.yokota.2000.521">Yokota et al 2000</xref>, <xref ref-type="bibr" rid="aved.REF.el_euchfayache.2014.402">El Euch-Fayache et al 2014</xref>, <xref ref-type="bibr" rid="aved.REF.ulatowski.2014.120">Ulatowski et al 2014</xref>]</p>
          <list list-type="bullet">
            <list-item>
              <p>Spinal sensory demyelination with neuronal atrophy and axonal spheroids</p>
            </list-item>
            <list-item>
              <p>Dying back-type degeneration of the posterior columns</p>
            </list-item>
            <list-item>
              <p>Neuronal lipofuscin accumulation in the third cortical layer of the cerebral cortex, thalamus, lateral geniculate body, spinal horns, and posterior root ganglia</p>
            </list-item>
            <list-item>
              <p>Fiber type grouping of the peroneus brevis muscle</p>
            </list-item>
            <list-item>
              <p>Mild loss of Purkinje cells</p>
            </list-item>
          </list>
        </sec>
        <sec id="aved.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>Presently no consensus diagnostic criteria for ataxia with vitamin E deficiency (AVED) exist.</p>
          <p>The diagnosis of AVED <bold>is established</bold> in a proband with all of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><related-object link-type="booklink" source-id="gene" document-id="friedreich" document-type="chapter">Friedreich ataxia</related-object>-like neurologic phenotype</p>
            </list-item>
            <list-item>
              <p>Markedly reduced plasma vitamin E (&#x003b1;-tocopherol) concentration</p>
            </list-item>
            <list-item>
              <p>Normal lipoprotein profile</p>
            </list-item>
            <list-item>
              <p>Exclusion of diseases that cause fat malabsorption</p>
            </list-item>
          </list>
          <p>Identification of biallelic <italic toggle="yes">TTPA</italic> pathogenic variants on molecular genetic testing (see <xref ref-type="table" rid="aved.T.molecular_genetic_testing_used_in">Table 1</xref>) establishes the diagnosis if clinical and laboratory features are inconclusive and confirms the diagnosis in individuals with the above features.</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive genomic testing</bold>:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">TTPA</italic> is performed first and followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found. Targeted analysis for <italic toggle="yes">TTPA</italic> pathogenic variant <xref ref-type="table" rid="aved.T.ttpa_pathogenic_variants_discusse">c.744delA</xref> can be performed first in individuals of Mediterranean or North African ancestry.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">TTPA</italic> and other genes of interest (see <xref ref-type="sec" rid="aved.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included and sensitivity of multi-gene panels vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel) fails to confirm a diagnosis in an individual with features of AVED. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation).</p>
              <p>For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="aved.T.molecular_genetic_testing_used_in" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Ataxia with Vitamin E Deficiency</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_aved.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_aved.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_aved.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_aved.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">TTPA</italic>
                  </td>
                  <td headers="hd_h_aved.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_aved.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;90%&#x000a0;<sup>4,&#x000a0;5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_aved.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_aved.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>7</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="aved.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="aved" object-id="aved.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="aved.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="aved.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="aved.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="aved.TF.1.4">
                <label>4. </label>
                <p><xref ref-type="bibr" rid="aved.REF.ouahchi.1995.141">Ouahchi et al [1995]</xref>, <xref ref-type="bibr" rid="aved.REF.hentati.1996.295">Hentati et al [1996]</xref>, <xref ref-type="bibr" rid="aved.REF.cavalier.1998.301">Cavalier et al [1998]</xref>, Schuelke [personal observation]. Sequence analysis identified at least one abnormal allele in 46 of 51 individuals with the AVED phenotype, who had clearly reduced plasma vitamin E concentration [Schuelke, personal observation]. In 132 Tunisian individuals with AVED, 91.7% were homozygous for the <xref ref-type="table" rid="aved.T.ttpa_pathogenic_variants_discusse">c.744delA</xref> pathogenic variant; 8.3% of individuals were homozygous for other pathogenic variants (c.205-1G&#x0003e;T, c.400C&#x0003e;T, c.552+2T&#x0003e;A) [<xref ref-type="bibr" rid="aved.REF.el_euchfayache.2014.402">El Euch-Fayache et al 2014</xref>]. Sequence analysis of cDNA was used to confirm a synonymous pathogenic variant resulting in loss of splice site [<xref ref-type="bibr" rid="aved.REF.schuelke.1999.240">Schuelke et al 1999</xref>] (see <xref ref-type="sec" rid="aved.Molecular_Genetics">Molecular Genetics</xref>).</p>
              </fn>
              <fn id="aved.TF.1.5">
                <label>5. </label>
                <p>Most individuals are homozygous or compound heterozygous for one of the known pathogenic variants.</p>
              </fn>
              <fn id="aved.TF.1.6">
                <label>6. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="aved.TF.1.7">
                <label>7. </label>
                <p>No data on detection rate of gene-targeted deletion/duplication analysis are available. A single whole-gene deletion has been reported [<xref ref-type="bibr" rid="aved.REF.kara.2008.471">Kara et al 2008</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="aved.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="aved.Clinical_Description">
          <title>Clinical Description</title>
          <p>The phenotype and disease severity of ataxia with vitamin E deficiency (AVED) vary widely. Although age of onset and disease course tend to be more uniform within a given family, symptoms and disease severity can vary among sibs [<xref ref-type="bibr" rid="aved.REF.shorer.1996.340">Shorer et al 1996</xref>].</p>
          <p>AVED generally manifests in late childhood or early teens between ages five and 15 years, however, the range may be from age two to 37 years as reported in a series of 132 North African individuals [<xref ref-type="bibr" rid="aved.REF.el_euchfayache.2014.402">El Euch-Fayache et al 2014</xref>]. The first symptoms include progressive ataxia, clumsiness of the hands, and loss of proprioception, especially of vibration and joint position sense. Handwriting deteriorates. In rare individuals, school performance declines secondary to loss of intellectual capacities. Tendon reflexes of the lower extremities are generally absent and the plantar reflexes increase in intensity. Affected individuals have difficulty walking in the dark and often have a positive Romberg sign. A high percentage of affected individuals (e.g., 8/11 individuals in one series) experience decreased visual acuity [<xref ref-type="bibr" rid="aved.REF.benomar.2002.25">Benomar et al 2002</xref>].</p>
          <p>In many individuals, cerebellar signs such as dysdiadochokinesia and dysarthria with a scanning speech pattern are present. One third of individuals have a characteristic head tremor (head titubation). In some persons, psychotic episodes, intellectual decline, and dystonic episodes have been described. Rarely, AVED may manifest as arm or cervical dystonia [<xref ref-type="bibr" rid="aved.REF.becker.2016.374">Becker et al 2016</xref>].</p>
          <p>Most untreated individuals become wheelchair dependent as a result of ataxia and/or leg weakness between ages 11 and 50 years [<xref ref-type="bibr" rid="aved.REF.harding.1985.32">Harding et al 1985</xref>, <xref ref-type="bibr" rid="aved.REF.ouahchi.1995.141">Ouahchi et al 1995</xref>, <xref ref-type="bibr" rid="aved.REF.hentati.1996.295">Hentati et al 1996</xref>, <xref ref-type="bibr" rid="aved.REF.cavalier.1998.301">Cavalier et al 1998</xref>, <xref ref-type="bibr" rid="aved.REF.gabsi.2001.477">Gabsi et al 2001</xref>, <xref ref-type="bibr" rid="aved.REF.benomar.2002.25">Benomar et al 2002</xref>, <xref ref-type="bibr" rid="aved.REF.mariotti.2004.130">Mariotti et al 2004</xref>].</p>
          <p>According to a large study on 132 individuals from North Africa [<xref ref-type="bibr" rid="aved.REF.el_euchfayache.2014.402">El Euch-Fayache et al 2014</xref>], the signs and symptoms include (in decreasing order of frequency):</p>
          <list list-type="bullet">
            <list-item>
              <p>Areflexia (94.7%)</p>
            </list-item>
            <list-item>
              <p>Gait impairment (93.4%)</p>
            </list-item>
            <list-item>
              <p>Positive Babinski sign (85.5%)</p>
            </list-item>
            <list-item>
              <p>Deep sensory disturbances (67.1%)</p>
            </list-item>
            <list-item>
              <p>Dysarthria (61.8%)</p>
            </list-item>
            <list-item>
              <p>Head tremor (40.8%)</p>
            </list-item>
            <list-item>
              <p>Urinary urgency (22.4%)</p>
            </list-item>
            <list-item>
              <p>Nystagmus (5.3%)</p>
            </list-item>
            <list-item>
              <p>Urinary incontinence (4.0%)</p>
            </list-item>
            <list-item>
              <p>Retinitis pigmentosa (2.3%)</p>
            </list-item>
            <list-item>
              <p>Cardiomyopathy (1.5%)</p>
            </list-item>
          </list>
        </sec>
        <sec id="aved.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>To date, only two pathogenic variants have shown clear-cut genotype-phenotype correlations:</p>
          <list list-type="bullet">
            <list-item>
              <p><xref ref-type="table" rid="aved.T.ttpa_pathogenic_variants_discusse"><bold>p.His101Gln</bold></xref> is associated with late-onset disease (age &#x0003e;30 years), a mild course, and increased risk for pigmentary retinopathy. This variant is primarily reported in individuals of Japanese descent.</p>
            </list-item>
            <list-item>
              <p><xref ref-type="table" rid="aved.T.ttpa_pathogenic_variants_discusse"><bold>c.744delA</bold></xref> is associated with early onset, a severe course, and slightly increased risk for cardiomyopathy. This variant is mainly observed in individuals of Mediterranean or North African descent. However, disease severity may vary considerably, and even in persons from the same family the onset of symptoms may vary between ages three and 12 years [<xref ref-type="bibr" rid="aved.REF.cavalier.1998.301">Cavalier et al 1998</xref>, <xref ref-type="bibr" rid="aved.REF.marzouki.2005.21">Marzouki et al 2005</xref>].</p>
            </list-item>
          </list>
          <p>A less clear genotype-phenotype correlation can be seen for the following pathogenic variants if they occur in homozygous form. Manifestation of disease:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Before age ten years.</bold> p.Arg59Trp, p.Arg134Ter, p.Glu141Lys, c.486delT, c.513_514insTT, c.530-531AG&#x0003e;GTAAGT (see <xref ref-type="table" rid="aved.T.ttpa_pathogenic_variants_discusse">Table 3</xref>)</p>
            </list-item>
            <list-item>
              <p><bold>After age ten years.</bold> p.Arg221Trp, p.Ala120Thr (see <xref ref-type="table" rid="aved.T.ttpa_pathogenic_variants_discusse">Table 3</xref>) [<xref ref-type="bibr" rid="aved.REF.cavalier.1998.301">Cavalier et al 1998</xref>]</p>
            </list-item>
          </list>
        </sec>
        <sec id="aved.Penetrance">
          <title>Penetrance</title>
          <p>AVED shows nearly complete penetrance in individuals who are homozygous or compound heterozygous for a <italic toggle="yes">TTPA</italic> pathogenic variant.</p>
        </sec>
        <sec id="aved.Nomenclature">
          <title>Nomenclature</title>
          <p>AVED was first called &#x0201c;Friedreich ataxia phenotype with selective vitamin E deficiency&#x0201d; [<xref ref-type="bibr" rid="aved.REF.ben_hamida.1993.195">Ben Hamida et al 1993</xref>].</p>
        </sec>
        <sec id="aved.Prevalence">
          <title>Prevalence</title>
          <p>Several restricted population-based studies have been performed.</p>
          <p><xref ref-type="bibr" rid="aved.REF.gotoda.1995.1313">Gotoda et al [1995]</xref> found one <italic toggle="yes">TTPA</italic> pathogenic variant (<xref ref-type="table" rid="aved.T.ttpa_pathogenic_variants_discusse">p.His101Gln</xref>) in 21 of 801 randomly selected inhabitants of a Japanese island on which one individual had previously been diagnosed with AVED. This would amount to a calculated prevalence of one homozygous individual per 1500 inhabitants. This pathogenic variant was not detected in 150 unrelated individuals from Tokyo.</p>
          <p>In a Moroccan study, AVED was diagnosed in 20% of individuals with a Friedreich ataxia-like phenotype [Benomar, personal communication].</p>
          <p>In a population study in southeast Norway, 1 in 171 individuals with hereditary ataxia was found to have AVED, suggesting a prevalence of 0.6:1,000,000 [<xref ref-type="bibr" rid="aved.REF.elkamil.2015.33">Elkamil et al 2015</xref>].</p>
          <p><xref ref-type="bibr" rid="aved.REF.anheim.2010.1">Anheim et al [2010]</xref> evaluated102 individuals with suspected autosomal recessive cerebellar ataxia; in 57 individuals (56%) a molecular diagnosis could be established. Of these, 36 had <related-object link-type="booklink" source-id="gene" document-id="friedreich" document-type="chapter">Friedreich ataxia</related-object> (FRDA), seven had <related-object link-type="booklink" source-id="gene" document-id="aoa2" document-type="chapter">ataxia with oculomotor apraxia type 2</related-object> (AOA2), four had <related-object link-type="booklink" source-id="gene" document-id="ataxia-telangiectas" document-type="chapter">ataxia-telangiectasia</related-object> (AT), three had <related-object link-type="booklink" source-id="gene" document-id="mss" document-type="chapter">Marinesco-Sj&#x000f6;gren syndrome</related-object> (MSS), three had <related-object link-type="booklink" source-id="gene" document-id="aoa" document-type="chapter">ataxia with oculomotor apraxia type 1</related-object> (AOA1), two had AR spastic ataxia of Charlevoix-Saguenay (<related-object link-type="booklink" source-id="gene" document-id="arsacs" document-type="chapter">ARSACS</related-object>), one had AR cerebellar ataxia (ARCA2), and one had ataxia with vitamin E deficiency (AVED). From their findings, the authors infer a prevalence for AVED in the Alsace region of France of approximately 1:1,800,000.</p>
          <p><xref ref-type="bibr" rid="aved.REF.zortea.2004.275">Zortea et al [2004]</xref> performed an epidemiologic study of inherited ataxias in the Italian province of Padua and found a prevalence of 3.5:1,000,000 for AVED.</p>
          <p>It also appears to be of interest that <italic toggle="yes">TTPA</italic> knockout mice are resistant to cerebral malaria and that this resistance can be abrogated by supplementation with vitamin E [<xref ref-type="bibr" rid="aved.REF.herbas.2010a.200">Herbas et al 2010a</xref>, <xref ref-type="bibr" rid="aved.REF.herbas.2010b.101">Herbas et al 2010b</xref>]. This may add <italic toggle="yes">TTPA</italic> pathogenic variants to several inherited alterations that confer protection against malaria [<xref ref-type="bibr" rid="aved.REF.l_pez.2010.1">L&#x000f3;pez et al 2010</xref>] and could explain the comparatively high prevalence of such pathogenic variants around the Mediterranean Sea.</p>
        </sec>
      </sec>
      <sec id="aved.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">TTPA</italic>.</p>
      </sec>
      <sec id="aved.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><related-object link-type="booklink" source-id="gene" document-id="friedreich" document-type="chapter"><bold>Friedreich ataxia</bold></related-object>
<bold>(FRDA).</bold> The age of onset is similar in ataxia with vitamin E deficiency (AVED) and FRDA; however, only in AVED are plasma vitamin E concentrations low [<xref ref-type="bibr" rid="aved.REF.benomar.2002.25">Benomar et al 2002</xref>].</p>
        <p>Certain clinical signs also help distinguish the two disorders (<xref ref-type="table" rid="aved.T.clinical_signs_that_help_distingu">Table 2</xref>); however, the distinction cannot be made on clinical grounds alone.</p>
        <table-wrap id="aved.T.clinical_signs_that_help_distingu" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Clinical Signs that Help Distinguish FRDA from AVED</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Clinical Sign</th>
                <th id="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">FRDA</th>
                <th id="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">AVED</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Cavus foot</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Rare</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Peripheral neuropathy</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Mild</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Diabetes mellitus type I</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">(+)</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Head titubation (tremor)</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Rare</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Amyotrophy</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x02013;</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Babinski sign</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">(+)</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Dystonia</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x02013;</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Retinitis pigmentosa</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x02013;</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">(+)</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Reduced visual acuity</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Rare</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Cardiac conduction disorder</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Rare</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Cardiomyopathy</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">(+)</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Muscle weakness</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x02013;</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Diabetes mellitus</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_aved.T.clinical_signs_that_help_distingu_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x02013;</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="aved.TF.2.1">
              <label>+ </label>
              <p>= generally present</p>
            </fn>
            <fn>
              <p>(+) = present only with certain pathogenic variants</p>
            </fn>
            <fn>
              <p>&#x02013; = generally absent</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>FRDA can be diagnosed based on molecular genetic testing and AVED based on plasma &#x003b1;-tocopherol concentration and molecular genetic testing of <italic toggle="yes">TTPA</italic>. Inheritance is autosomal recessive.</p>
        <p><bold>Abetalipoproteinemia (Bassen-Kornzweig) and hypobetalipoproteinemia</bold>. Features include retinitis pigmentosa, progressive ataxia, steatorrhea, demyelinating neuropathy, dystonia, extrapyramidal signs, spastic paraparesis (rare), and acanthocytosis together with vitamin E deficiency, which is secondary to defective intestinal absorption of lipids. The serum cholesterol concentration is very low, and serum &#x003b2;-lipoproteins are absent. Low-density lipoproteins (LDLs) and very low-density lipoproteins (VLDLs) cannot be synthesized properly. Abetalipoproteinemia (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/200100">200100</ext-link>) is caused by pathogenic variants in <italic toggle="yes">MTP</italic>, which encodes microsomal triglyceride transfer protein large subunit. Hypobetalipoproteinemia (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/615558">615558</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/605019">605019</ext-link>) is caused by pathogenic variants in <italic toggle="yes">APOB</italic> (encoding apolipoprotein B-100) or <italic toggle="yes">ANGPTL3</italic> (encoding angiopoietin-related protein 3). Inheritance is autosomal recessive.</p>
        <p><bold>Malnutrition/reduced vitamin E uptake.</bold> To become vitamin E deficient, healthy individuals have to consume a diet depleted in vitamin E over months. This is sometimes seen in individuals, especially children, who eat a highly unbalanced diet (e.g., Zen macrobiotic diet), but is most often observed in chronic diseases that impede the resorption of fat-soluble vitamins in the distal ileum (e.g., cholestatic liver disease, short bowel syndrome, <related-object link-type="booklink" source-id="gene" document-id="cf" document-type="chapter">cystic fibrosis</related-object>, Crohn's disease). The symptoms are similar to AVED. Although such individuals should be supplemented with oral preparations of vitamin E, they do not need the high doses necessary for treatment of AVED.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="refsum" document-type="chapter"><bold>Refsum disease</bold></related-object><bold>.</bold> Findings are early-onset retinitis pigmentosa, chronic polyneuropathy, deafness, and cerebellar ataxia. Many individuals have cardiac conduction disorders and ichthyosis. In Refsum disease, the degradation of phytanic acid is impeded because of pathogenic variants in the gene encoding phytanoyl-CoA hydroxylase (<italic toggle="yes">PHYH</italic>) or the gene encoding the PTS2 receptor (<italic toggle="yes">PEX7</italic>). High serum concentration of phytanic acid differentiates Refsum disease from AVED. Inheritance is autosomal recessive.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="cmt1" document-type="chapter"><bold>Charcot-Marie-Tooth neuropathy type 1A</bold></related-object>
<bold>(CMT1A).</bold> Findings are sensorimotor neuropathy with areflexia, cavus foot, and muscle wasting and weakness, especially in the lower legs and of the interdigital muscles. Neuropathy can be verified by presence of reduced NCVs (&#x0003c;38 m/s). CMT1A is caused by duplication of <italic toggle="yes">PMP22,</italic> the gene encoding peripheral myelin protein 22. The plasma vitamin E concentrations in CMT1A are normal. Inheritance is autosomal dominant.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="aoa" document-type="chapter"><bold>Ataxia with oculomotor apraxia type 1</bold></related-object>
<bold>(AOA1).</bold> Findings are oculomotor apraxia, cerebellar ataxia, peripheral neuropathy, and choreoathetosis. Hypoalbuminemia and hypercholesterolemia may occur. AOA1 neurologically mimics ataxia-telangiectasia, but without telangiectasias or immunodeficiency. Plasma vitamin E levels are normal [<xref ref-type="bibr" rid="aved.REF.anheim.2010.1">Anheim et al 2010</xref>]. AOA1 is caused by pathogenic variants in the gene encoding aprataxin (<italic toggle="yes">APTX</italic>). Inheritance is autosomal recessive.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="aoa2" document-type="chapter"><bold>Ataxia with oculomotor apraxia type 2</bold></related-object>
<bold>(AOA2).</bold> Findings are spinocerebellar ataxia and, rarely, oculomotor apraxia. Serum concentrations of creatine kinase, &#x003b3;-globulin, and &#x003b1;-fetoprotein (AFP) are increased. AOA2 is caused by pathogenic variants in <italic toggle="yes">SETX</italic>, the gene encoding probable helicase senataxin. Plasma vitamin E levels are normal [<xref ref-type="bibr" rid="aved.REF.anheim.2010.1">Anheim et al 2010</xref>]. Inheritance is autosomal recessive.</p>
        <p><bold>Other ataxias.</bold> Because AVED typically presents with ataxia or clumsiness in late childhood, AVED should be included in the differential diagnosis of all ataxias with the same age of onset (see <related-object link-type="booklink" source-id="gene" document-id="ataxias" document-type="chapter">Hereditary Ataxia Overview</related-object>), including the following:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="ataxia-telangiectas" document-type="chapter"><bold>Ataxia-telangiectasia</bold></related-object><bold>.</bold> Findings are cerebellar ataxia, seizures, nystagmus, conjunctival telangiectasias, hypogonadism, immunodeficiency, frequent pulmonary infections, and neoplasia. Plasma vitamin E levels are normal [<xref ref-type="bibr" rid="aved.REF.anheim.2010.1">Anheim et al 2010</xref>]. Ataxia-telangiectasia is caused by pathogenic variants in <italic toggle="yes">ATM</italic>; inheritance is autosomal recessive.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="mss" document-type="chapter"><bold>Marinesco-Sj&#x000f6;gren syndrome</bold></related-object><bold>.</bold> Findings are cerebellar ataxia, intellectual disability, dysarthria, cataracts, short stature, and hypergonadotropic hypogonadism. Marinesco-Sj&#x000f6;gren syndrome is caused by pathogenic variants in <italic toggle="yes">SIL1</italic>; inheritance is autosomal recessive.</p>
          </list-item>
          <list-item>
            <p><bold>Chylomicron retention disease (Anderson disease)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/246700">246700</ext-link>). Clinical findings are infantile-onset malabsorption of fat and fat-soluble vitamins, diarrhea, and neurologic deficits (peripheral neuropathy, absent tendon reflexes, diminished vibratory sense). The disease is caused by pathogenic variants in <italic toggle="yes">SAR1B</italic> that cause the absence of chylomicrons due to a defect of chylomicron secretion [<xref ref-type="bibr" rid="aved.REF.aguglia.2000.260">Aguglia et al 2000</xref>]. Inheritance is autosomal recessive.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="ccfdn" document-type="chapter"><bold>Congenital cataracts, facial dysmorphism, neuropathy</bold></related-object><bold>.</bold> Clinical findings are congenital cataracts, cerebellar ataxia, cavus foot deformity, facial dysmorphisms, delayed motor development, and pyramidal signs. The affected individuals are of Roma/Gypsy origin and are all homozygous for the same pathogenic variant in intron 6 of <italic toggle="yes">CTDP1</italic>. Inheritance is autosomal recessive.</p>
          </list-item>
          <list-item>
            <p><bold>Pyruvate dehydrogenase E1 alpha deficiency</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/312170">312170</ext-link>). Findings are episodic ataxia, intellectual disability, hypotonia, cerebellar atrophy, dystonia, and lactic acidosis. The disease is caused by pathogenic variants in <italic toggle="yes">PDHA1</italic>; inheritance is X-linked. A high proportion of heterozygous females manifest severe symptoms.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="sider-anemia" document-type="chapter"><bold>Sideroblastic anemia and ataxia</bold></related-object><bold>.</bold> Findings are early-onset non-progressive cerebellar ataxia, hyperreflexia, tremor, dysdiadochokinesia, and hypochromic microcytic anemia. The disease is caused by pathogenic variants in <italic toggle="yes">ABCB7</italic>; inheritance is X-linked.</p>
          </list-item>
          <list-item>
            <p><bold>Cayman-type cerebellar ataxia</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/601238">601238</ext-link>). Findings are cerebellar ataxia with wide-based gait, psychomotor retardation, intention tremor, and dysarthria. The disease is caused by pathogenic variants in <italic toggle="yes">ATCAY</italic>; inheritance is autosomal recessive.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="syne1ca-ar" document-type="chapter"><bold><italic toggle="yes">SYNE1</italic>-related autosomal recessive cerebellar ataxia</bold></related-object> (also known as autosomal recessive spinocerebellar ataxia [SCAR8] and autosomal recessive cerebellar ataxia type 1 [ARCA1]). Findings are adult-onset cerebellar ataxia and/or dysarthria. Dysmetria, brisk lower-extremity tendon reflexes, and minor abnormalities in ocular saccades and pursuit can be seen. ARCA1 has not been observed outside of Quebec, Canada.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="joubert" document-type="chapter"><bold>Joubert syndrome</bold></related-object><bold>.</bold> Findings are truncal ataxia, developmental delays, episodic hyperpnea or apnea, and atypical eye movements. Cognitive abilities range from severe intellectual disability to normal. Variable features include retinal dystrophy, renal disease, ocular coloboma, occipital encephalocele, hepatic fibrosis, polydactyly, oral hamartomas, and endocrine abnormalities. The characteristic finding on MRI is the "molar tooth sign" in which hypoplasia of the cerebellar vermis and accompanying brain stem abnormalities resemble a tooth. More than twenty genes are associated with Joubert syndrome (pathogenic variants in which appear to account for only about 50% of cases). Inheritance is autosomal recessive.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="ctx" document-type="chapter"><bold>Cerebrotendinous xanthomatosis</bold></related-object><bold>.</bold> Clinical features include xanthomas of the Achilles and other tendons, cerebellar ataxia beginning after puberty, juvenile cataracts, early atherosclerosis, and progressive dementia. The disease is caused by pathogenic variants in <italic toggle="yes">CYP27A1</italic> (encoding sterol 27-hydroxylase, mitochondrial). Inheritance is autosomal recessive.</p>
          </list-item>
        </list>
      </sec>
      <sec id="aved.Management">
        <title>Management</title>
        <sec id="aved.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with ataxia with vitamin E deficiency (AVED), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Clinical neurologic examination &#x02013; particularly reflex status, vibratory and position sense, gait, Babinski sign, tremor, dysarthria</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic examination for evidence of macular degeneration or retinitis pigmentosa and decreased visual acuity; electroretinogram (ERG)</p>
            </list-item>
            <list-item>
              <p>Cardiac examination; echocardiography and ECG to assess for cardiomyopathy</p>
            </list-item>
            <list-item>
              <p>Neurophysiologic examination; nerve conduction velocity (NCV) and somatosensory potentials (especially the central conduction time [<xref ref-type="bibr" rid="aved.REF.schuelke.1999.240">Schuelke et al 1999</xref>]), which are good objective measures of neurologic improvement after vitamin E supplementation</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="aved.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The treatment of choice for AVED is lifelong high-dose oral vitamin E supplementation. Some symptoms (e.g., ataxia and intellectual deterioration) can be reversed if treatment is initiated early in the disease process [<xref ref-type="bibr" rid="aved.REF.schuelke.1999.240">Schuelke et al 1999</xref>]. In older individuals, disease progression can be stopped, but deficits in proprioception and gait unsteadiness generally remain [<xref ref-type="bibr" rid="aved.REF.gabsi.2001.477">Gabsi et al 2001</xref>, <xref ref-type="bibr" rid="aved.REF.mariotti.2004.130">Mariotti et al 2004</xref>, <xref ref-type="bibr" rid="aved.REF.el_euchfayache.2014.402">El Euch-Fayache et al 2014</xref>]. With treatment, plasma vitamin E concentrations can become normal.</p>
          <p>In presymptomatic individuals, the manifestations of AVED can be prevented if vitamin E supplementation is initiated early [<xref ref-type="bibr" rid="aved.REF.el_euchfayache.2014.402">El Euch-Fayache et al 2014</xref>].</p>
          <p>No large-scale therapeutic studies have been performed to determine optimal vitamin E dosage and to evaluate outcomes.</p>
          <p>The reported vitamin E dose ranges from 800 mg to 1500 mg (or 40 mg/kg body weight in children) [<xref ref-type="bibr" rid="aved.REF.burck.1981.267">Burck et al 1981</xref>, <xref ref-type="bibr" rid="aved.REF.harding.1985.32">Harding et al 1985</xref>, <xref ref-type="bibr" rid="aved.REF.amiel.1995.333">Amiel et al 1995</xref>, <xref ref-type="bibr" rid="aved.REF.cavalier.1998.301">Cavalier et al 1998</xref>, <xref ref-type="bibr" rid="aved.REF.schuelke.1999.240">Schuelke et al 1999</xref>, <xref ref-type="bibr" rid="aved.REF.schuelke.2000b.1584">Schuelke et al 2000b</xref>, <xref ref-type="bibr" rid="aved.REF.gabsi.2001.477">Gabsi et al 2001</xref>, <xref ref-type="bibr" rid="aved.REF.mariotti.2004.130">Mariotti et al 2004</xref>].</p>
          <p>One of the following vitamin E preparations is used:</p>
          <list list-type="bullet">
            <list-item>
              <p>The chemically manufactured racemic form, <italic toggle="yes">all-rac</italic>-&#x003b1;-tocopherol acetate</p>
            </list-item>
            <list-item>
              <p>The naturally occurring form, <italic toggle="yes">RRR</italic>-&#x003b1;-tocopherol</p>
            </list-item>
          </list>
          <p>It is currently unknown whether affected individuals should be treated with <italic toggle="yes">all-rac</italic>-&#x003b1;-tocopherol acetate or with <italic toggle="yes">RRR</italic>-&#x003b1;-tocopherol. It is known that alpha-TTP (&#x003b1;TPP) stereoselectively binds and transports <italic toggle="yes">2R</italic>-&#x003b1;-tocopherols [<xref ref-type="bibr" rid="aved.REF.weiser.1996.2539">Weiser et al 1996</xref>, <xref ref-type="bibr" rid="aved.REF.hosomi.1997.105">Hosomi et al 1997</xref>, <xref ref-type="bibr" rid="aved.REF.leonard.2002.555">Leonard et al 2002</xref>]. For some <italic toggle="yes">TTPA</italic> pathogenic variants, this stereoselective binding capacity is lost and affected individuals cannot discriminate between <italic toggle="yes">RRR</italic>- and <italic toggle="yes">SRR</italic>-&#x003b1;-tocopherol [<xref ref-type="bibr" rid="aved.REF.traber.1993.201">Traber et al 1993</xref>, <xref ref-type="bibr" rid="aved.REF.cavalier.1998.301">Cavalier et al 1998</xref>]. In this instance, affected individuals would also be able to incorporate non-<italic toggle="yes">2R</italic>-&#x003b1;-tocopherol stereoisomers into their bodies if they were supplemented with <italic toggle="yes">all-rac</italic>-&#x003b1;-tocopherol. Since potential adverse effects of the synthetic stereoisomers have not been studied in detail, it seems appropriate to treat with <italic toggle="yes">RRR</italic>-&#x003b1;-tocopherol, despite the higher cost.</p>
        </sec>
        <sec id="aved.Prevention_of_Primary_Manifestation">
          <title>Prevention of Primary Manifestations</title>
          <p>If vitamin E treatment is initiated in presymptomatic individuals (e.g., younger sibs of an index case), the symptoms of AVED do not develop [<xref ref-type="bibr" rid="aved.REF.amiel.1995.333">Amiel et al 1995</xref>, <xref ref-type="bibr" rid="aved.REF.el_euchfayache.2014.402">El Euch-Fayache et al 2014</xref>].</p>
        </sec>
        <sec id="aved.Surveillance">
          <title>Surveillance</title>
          <p>During vitamin E therapy, the plasma vitamin E concentration should be measured at regular intervals (e.g., every 6 months), especially in children. Ideally the plasma vitamin E concentration should be maintained in the high normal range.</p>
          <p>Some protocols call for measuring the total radical-trapping antioxidant parameter of plasma (TRAP). Although &#x003b1;-tocopherol only contributes 5%-10% to TRAP, this parameter appears to be the best surrogate marker for clinical improvement [<xref ref-type="bibr" rid="aved.REF.schuelke.1999.240">Schuelke et al 1999</xref>]. Discontinuation of vitamin E supplementation, even temporarily, leads to a drop in plasma vitamin E concentration within two to three days and to a prolonged drop in TRAP, even after reinitiating vitamin E supplementation [<xref ref-type="bibr" rid="aved.REF.kohlsch_tter.1997.581">Kohlsch&#x000fc;tter et al 1997</xref>, <xref ref-type="bibr" rid="aved.REF.schuelke.2000b.1584">Schuelke et al 2000b</xref>].</p>
        </sec>
        <sec id="aved.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Individuals with AVED should avoid:</p>
          <list list-type="bullet">
            <list-item>
              <p>Smoking because it considerably lowers TRAP and reduces plasma vitamin E concentrations [<xref ref-type="bibr" rid="aved.REF.sharpe.1996.223">Sharpe et al 1996</xref>];</p>
            </list-item>
            <list-item>
              <p>Occupations requiring quick responses or good balance.</p>
            </list-item>
          </list>
        </sec>
        <sec id="aved.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Predictive testing should be offered to all sibs of a proband, as timely treatment with vitamin E supplementation may completely avert the clinical manifestations of the disease.</p>
          <list list-type="bullet">
            <list-item>
              <p>All relatives at risk, especially younger sibs of a proband, should be evaluated for vitamin E deficiency.</p>
            </list-item>
            <list-item>
              <p>If plasma vitamin E concentration is low, the person should be tested for presence of the <italic toggle="yes">TTPA</italic> pathogenic variants found in the proband so that individuals with biallelic pathogenic variants can be treated promptly with vitamin E supplementation.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="aved.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="aved.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Reduced vitamin E levels are associated with low fertility and embryo resorption in mice [<xref ref-type="bibr" rid="aved.REF.traber.2012.330">Traber &#x00026; Manor 2012</xref>] and &#x003b1;-tocopherol transfer protein is highly expressed in the human placenta [<xref ref-type="bibr" rid="aved.REF.m_llerschmehl.2004.413">M&#x000fc;ller-Schmehl et al 2004</xref>]; therefore, it is advisable to keep vitamin E levels in the high normal range during pregnancy.</p>
        </sec>
        <sec id="aved.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
        <sec id="aved.Other">
          <title>Other</title>
          <p>Because of abnormal position sense in the extremities, individuals with AVED may have difficulty riding a bicycle or driving a car. Before attempting to drive a car, affected individuals need to be tested by a physician to determine whether they can drive safely.</p>
        </sec>
      </sec>
      <sec id="aved.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="aved.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Ataxia with vitamin E deficiency (AVED) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="aved.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">TTPA</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with AVED are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">TTPA</italic>.</p>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier of a pathogenic variant in <italic toggle="yes">TTPA</italic>.</p>
        </sec>
        <sec id="aved.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">TTPA</italic> pathogenic variants in the family.</p>
          <p>The moderately lowered plasma vitamin E concentration in heterozygotes is not a sensitive enough measure to distinguish between heterozygous carriers and non-carriers.</p>
        </sec>
        <sec id="aved.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Predictive testing of at-risk family members.</bold> Because vitamin E treatment initiated in presymptomatic individuals can prevent the findings of AVED [<xref ref-type="bibr" rid="aved.REF.amiel.1995.333">Amiel et al 1995</xref>], predictive testing of at-risk family members (particularly younger sibs of the proband) is appropriate. See Management, <xref ref-type="sec" rid="aved.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="aved.Prenatal_Testing_and_Preimplantatio">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">TTPA</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for AVED are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="aved.Resources">
        <title>Resources</title>
      </sec>
      <sec id="aved.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">TTPA</italic> consists of five uniformly spliced exons (ENST00000260116) with an open reading frame of 834 bp. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="aved" object-id="aved.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> Pathogenic variants of <italic toggle="yes">TTPA</italic> comprise nonsense, missense, and splice site variants as well as small deletions, insertions, and indels (i.e., simultaneous deletion and insertion) (see <xref ref-type="table" rid="aved.T.ttpa_pathogenic_variants_discusse">Table 3</xref>). Most affected individuals have private pathogenic variants. Only the c.744delA and the c.513_514insTT pathogenic variants occur more often, especially in individuals of Mediterranean or North African descent. In a study of 33 individuals with AVED, the c.744delA pathogenic variant was found on both alleles in 11 individuals and on one allele in one individual [<xref ref-type="bibr" rid="aved.REF.cavalier.1998.301">Cavalier et al 1998</xref>]. Putative splice defects can be investigated experimentally by analysis of cDNA from Epstein-Barr virus (EBV)-immortalized lymphoblastoid cell lines [<xref ref-type="bibr" rid="aved.REF.schuelke.1999.240">Schuelke et al 1999</xref>].</p>
        <p>For more information, see <related-object source-id="gene" document-id="aved" object-id="aved.molgen.TA">Table A</related-object>.</p>
        <table-wrap id="aved.T.ttpa_pathogenic_variants_discusse" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p><italic toggle="yes">TTPA</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.175C&#x0003e;T</td>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg59Trp</td>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_3" rowspan="14" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nucleotide/50592999">NM_000370.2</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/4507723">NP_000361.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.191A&#x0003e;G</td>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asp64Gly</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.303T&#x0003e;G</td>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.His101Gln</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.358G&#x0003e;A</td>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala120Thr</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.400C&#x0003e;T</td>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg134Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.421G&#x0003e;A</td>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu141Lys</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.486delT</td>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Trp163GlyfsTer13</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.513_514insTT</td>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr172LeufsTer5</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.530-531AG&#x0003e;GTAAGT</td>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Lys177SerfsTer3</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.548T&#x0003e;C</td>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu183Pro</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.575G&#x0003e;A</td>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg192His</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.661C&#x0003e;T</td>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg221Trp</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.736G&#x0003e;C</td>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly246Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.744delA</td>
                <td headers="hd_h_aved.T.ttpa_pathogenic_variants_discusse_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu249AsnfsTer15</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The transcript encodes the 278-amino acid protein, &#x003b1;-tocopherol transfer protein (&#x003b1;TTP). This cytosolic 31.7-kd protein is mainly expressed in liver cells [<xref ref-type="bibr" rid="aved.REF.sato.1993.17705">Sato et al 1993</xref>] but also in the pyramidal cells of the cerebellum [<xref ref-type="bibr" rid="aved.REF.hosomi.1998.159">Hosomi et al 1998</xref>, <xref ref-type="bibr" rid="aved.REF.copp.1999.80">Copp et al 1999</xref>] and in the placenta [<xref ref-type="bibr" rid="aved.REF.kaempfrotzoll.2003.439">Kaempf-Rotzoll et al 2003</xref>, <xref ref-type="bibr" rid="aved.REF.m_llerschmehl.2004.413">M&#x000fc;ller-Schmehl et al 2004</xref>].</p>
        <p>Liver-&#x003b1;TPP incorporates the &#x003b1;-tocopherol from the chylomicrons into VLDLs, which are then secreted into the circulation [<xref ref-type="bibr" rid="aved.REF.traber.1990.397">Traber et al 1990</xref>] &#x02013; a stereoselective process that favors <italic toggle="yes">2R</italic>-&#x003b1;-tocopherols [<xref ref-type="bibr" rid="aved.REF.weiser.1996.2539">Weiser et al 1996</xref>, <xref ref-type="bibr" rid="aved.REF.leonard.2002.555">Leonard et al 2002</xref>]. In the absence of &#x003b1;TPP, &#x003b1;-tocopherol is rapidly lost into the urine [<xref ref-type="bibr" rid="aved.REF.schuelke.2000a.1543">Schuelke et al 2000a</xref>]. Alpha TTP appears to have two functions that can be tested separately: (1) the stereoselective binding of <italic toggle="yes">2R</italic>-&#x003b1;-tocopherols and (2) the transfer of &#x003b1;-tocopherol between membranes [<xref ref-type="bibr" rid="aved.REF.gotoda.1995.1313">Gotoda et al 1995</xref>, <xref ref-type="bibr" rid="aved.REF.morley.2004.4143">Morley et al 2004</xref>]. In the hepatocytes, &#x003b1;TPP appears to direct vitamin E trafficking from the endocytic compartment to transport vesicles that deliver the vitamin to the site of secretion at the plasma membrane. In the presence of <italic toggle="yes">TTPA</italic> pathogenic variants (p.Arg59Trp, p.Arg221Trp, p.Ala120Thr), vitamin E did not travel to the plasma membrane and remained trapped in the lysosomes. The authors also reported that the impact of the pathogenic variant on protein stability appears to be directly related to the clinical phenotype [<xref ref-type="bibr" rid="aved.REF.qian.2006.8236">Qian et al 2006</xref>].</p>
        <p>Alpha-TTP has two CRAL-TRIO domains (AA 11-83 and 89-275). These domains were first described in the cellular retinaldehyde-binding protein (CRALBP) and the trifunctional protein (TRIO) [<xref ref-type="bibr" rid="aved.REF.crabb.1988.18678">Crabb et al 1988</xref>, <xref ref-type="bibr" rid="aved.REF.debant.1996.5466">Debant et al 1996</xref>]. Other proteins of this family include a phosphatidyl inositol/phosphatidyl choline transfer protein (Sec14p) of yeast [<xref ref-type="bibr" rid="aved.REF.sha.1998.506">Sha et al 1998</xref>] and the tocopherol-associated protein (TAP or SEC14 like 2) [<xref ref-type="bibr" rid="aved.REF.zimmer.2000.25672">Zimmer et al 2000</xref>]. Pathogenic variants in caytaxin, another CRAL-TRIO protein, cause ataxia in humans (Cayman ataxia) as well [<xref ref-type="bibr" rid="aved.REF.bomar.2003.264">Bomar et al 2003</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Fourteen of 26 known pathogenic variants in <italic toggle="yes">TTPA</italic> predict a truncated protein through missplicing or generation of a premature termination codon. Pathogenic missense variants that cause substitutions in non- or semi-conserved amino acids (e.g., p.His101Gln, p.Ala120Thr, p.Arg192His, or p.Gly246Arg) cause a mild phenotype, whereas substitutions in highly conserved amino acids are associated with early onset and severe symptoms (e.g., p.Arg59Trp, p.Asp64Gly, p.Glu141Lys, p.Leu183Pro, p.Arg221Trp).</p>
        <p>Through the x-ray crystallographic structure of &#x003b1;TPP [<xref ref-type="bibr" rid="aved.REF.meier.2003.725">Meier et al 2003</xref>, <xref ref-type="bibr" rid="aved.REF.min.2003.14713">Min et al 2003</xref>], the impact of some pathogenic variants on the protein structure and function may be explained. Of ten pathogenic missense variants, only one (p.Leu183Pro) is located in the &#x003b1;-tocopherol binding pouch. There is a highly positively charged arginine cluster on the surface of the protein, where &#x003b1;TPP probably interacts with other binding partners. Pathogenic variants of these conserved amino acids, Arg59 and Arg221 cause a severe AVED phenotype.</p>
        <p>Biochemical investigations of the in vitro capacity of &#x003b1;TPP to bind and to transfer &#x003b1;-tocopherol revealed a reduction in both functions for the p.Arg59Trp, p.Glu141Lys, and p.Arg221Trp pathogenic variants. In contrast, the pathogenic variants associated with the mild AVED phenotype (p.His101Gln, p.Ala120Thr) do not have a pronounced effect on &#x003b1;TPP in vitro function. It has been hypothesized that the pathology of these pathogenic variants may derive from other as-yet-unknown &#x003b1;TPP functions [<xref ref-type="bibr" rid="aved.REF.morley.2004.4143">Morley et al 2004</xref>]. Both types of pathogenic variants may impair the ability of &#x003b1;TPP to facilitate the secretion of vitamin E from cells where it remains trapped in lysosomes [<xref ref-type="bibr" rid="aved.REF.qian.2006.8236">Qian et al 2006</xref>]. On the other hand, binding of vitamin E to &#x003b1;TPP prevents its ubiquinylation and its subsequent proteolytic degradation through the proteasome [<xref ref-type="bibr" rid="aved.REF.thakur.2010.9339">Thakur et al 2010</xref>].</p>
      </sec>
      <sec id="aved.References">
        <title>References</title>
        <sec id="aved.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="aved.Literature_Cited.reflist0">
            <ref id="aved.REF.aguglia.2000.260">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aguglia</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Annesi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquinelli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spadafora</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gambardella</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Annesi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasqua</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavalcanti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crescibene</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bagala</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bono</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliveri</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valentino</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zappia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quattrone</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Vitamin E deficiency due to chylomicron retention disease in Marinesco-Sjogren syndrome.</article-title>
                <source>Ann Neurol</source>
                <volume>47</volume>
                <fpage>260</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">10665502</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.amiel.1995.333">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Amiel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maziere</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beucler</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reutenauer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loux</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnefont</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landrieu</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Familial isolated vitamin E deficiency. Extensive study of a large family with a 5-year therapeutic follow-up.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>18</volume>
                <fpage>333</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">7474901</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.anheim.2010.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Anheim</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleury</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monga</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laugel</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaigne</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodier</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ginglinger</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boulay</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Courtois</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drouot</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fritsch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delaunoy</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoppa-Lyonnet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tranchant</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management.</article-title>
                <source>Neurogenetics</source>
                <volume>11</volume>
                <fpage>1</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">19440741</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.becker.2016.374">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargas</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearson</surname>
                    <given-names>TS</given-names>
                  </name>
                </person-group>
                <article-title>Ataxia with vitamin E deficiency may present with cervical dystonia.</article-title>
                <source>Tremor Other Hyperkinet Mov (N Y)</source>
                <year>2016</year>
                <volume>6</volume>
                <fpage>374</fpage>
                <pub-id pub-id-type="pmid">27274910</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.ben_hamida.1993.195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ben Hamida</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doerflinger</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linder</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reutenauer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gyapay</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vignal</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Paslier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pandolfo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mokini</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Novelli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben Hamida</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>J-L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x00153;nig</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping.</article-title>
                <source>Nat Genet.</source>
                <year>1993</year>
                <volume>5</volume>
                <fpage>195</fpage>
                <lpage>200</lpage>
                <pub-id pub-id-type="pmid">8252047</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.benomar.2002.25">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Benomar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yahyaoui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meggouh</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouhouche</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boutchich</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouslam</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaim</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belaidi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ouazzani</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chkili</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Clinical comparison between AVED patients with 744 del A mutation and Friedreich ataxia with GAA expansion in 15 Moroccan families.</article-title>
                <source>J Neurol Sci</source>
                <volume>198</volume>
                <fpage>25</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12039660</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.bomar.2003.264">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bomar</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benke</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slattery</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puttagunta</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>LP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seong</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nystuen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albin</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kittles</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheffield</surname>
                    <given-names>VC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burmeister</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutations in a novel gene encoding a CRAL-TRIO domain cause human Cayman ataxia and ataxia/dystonia in the jittery mouse.</article-title>
                <source>Nat Genet</source>
                <volume>35</volume>
                <fpage>264</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14556008</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.burck.1981.267">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Burck</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuhlendahl</surname>
                    <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <year>1981</year>
                <article-title>Neuromyopathy and vitamin E deficiency in man.</article-title>
                <source>Neuropediatrics</source>
                <volume>12</volume>
                <fpage>267</fpage>
                <lpage>78</lpage>
                <pub-id pub-id-type="pmid">6945489</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.cavalier.1998.301">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cavalier</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ouahchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kayden</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Donato</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reutenauer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families.</article-title>
                <source>Am J Hum Genet</source>
                <volume>62</volume>
                <fpage>301</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">9463307</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.copp.1999.80">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Copp</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wisniewski</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larnaout</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben Hamida</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kayden</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders.</article-title>
                <source>Brain Res</source>
                <volume>822</volume>
                <fpage>80</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10082886</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.crabb.1988.18678">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Crabb</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carr</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armes</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saari</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>The complete primary structure of the cellular retinaldehyde-binding protein from bovine retina.</article-title>
                <source>J Biol Chem</source>
                <volume>263</volume>
                <fpage>18678</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">3198594</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.debant.1996.5466">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Debant</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serra-Pages</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seipel</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Brien</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Streuli</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>93</volume>
                <fpage>5466</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">8643598</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.el_euchfayache.2014.402">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>El Euch-Fayache</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouhlal</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amouri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Molecular, clinical and peripheral neuropathy study of Tunisian patient with ataxia with vitamin E deficiency.</article-title>
                <source>Brain</source>
                <volume>137</volume>
                <fpage>402</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">24369383</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.elkamil.2015.33">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Elkamil</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johansen</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aasly</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Ataxia with vitamin e deficiency in norway.</article-title>
                <source>J Mov Disord.</source>
                <year>2015</year>
                <volume>8</volume>
                <fpage>33</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">25614784</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.finckh.1995.210">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Finckh</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kontush</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Commentz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hubner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burdelski</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlschutter</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Monitoring of ubiquinol-10, ubiquinone-10, carotenoids, and tocopherols in neonatal plasma microsamples using high-performance liquid chromatography with coulometric electrochemical detection.</article-title>
                <source>Anal Biochem</source>
                <volume>232</volume>
                <fpage>210</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">8747477</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.gabsi.2001.477">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gabsi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gouider-Khouja</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kefi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turki</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben Hamida</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kayden</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mebazaa</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Effect of vitamin E supplementation in patients with ataxia with vitamin E deficiency.</article-title>
                <source>Eur J Neurol</source>
                <volume>8</volume>
                <fpage>477</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">11554913</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.gotoda.1995.1313">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gotoda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokota</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukuo</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yazaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol-transfer protein.</article-title>
                <source>N Engl J Med</source>
                <volume>333</volume>
                <fpage>1313</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">7566022</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.harding.1985.32">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthews</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellis</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Booth</surname>
                    <given-names>IW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>DP</given-names>
                  </name>
                </person-group>
                <year>1985</year>
                <article-title>Spinocerebellar degeneration associated with a selective defect of vitamin E absorption.</article-title>
                <source>N Engl J Med</source>
                <volume>313</volume>
                <fpage>32</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">4000224</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.hentati.1996.295">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deng</surname>
                    <given-names>HX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hung</surname>
                    <given-names>WY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nayer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmed</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tim</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stumpf</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siddique</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Ahmed. Human alpha-tocopherol transfer protein: gene structure and mutations in familial vitamin E deficiency.</article-title>
                <source>Ann Neurol.</source>
                <year>1996</year>
                <volume>39</volume>
                <fpage>295</fpage>
                <lpage>300</lpage>
                <pub-id pub-id-type="pmid">8602747</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.herbas.2010a.200">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Herbas</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okazaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terao</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xuan</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2010a</year>
                <article-title>Alpha-tocopherol transfer protein inhibition is effective in the prevention of cerebral malaria in mice.</article-title>
                <source>Am J Clin Nutr</source>
                <volume>91</volume>
                <fpage>200</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19923370</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.herbas.2010b.101">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Herbas</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueta</surname>
                    <given-names>YY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ichikawa</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiba</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishibashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shichiri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukumoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokoyama</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeya</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xuan</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2010b</year>
                <article-title>Alpha-tocopherol transfer protein disruption confers resistance to malarial infection in mice.</article-title>
                <source>Malar J.</source>
                <volume>9</volume>
                <fpage>101</fpage>
                <pub-id pub-id-type="pmid">20403155</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.hosomi.1997.105">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hosomi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiyose</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Igarashi</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs.</article-title>
                <source>FEBS Lett</source>
                <volume>409</volume>
                <fpage>105</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9199513</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.hosomi.1998.159">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hosomi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwatsubo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokota</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Localization of alpha-tocopherol transfer protein in rat brain.</article-title>
                <source>Neurosci Lett.</source>
                <volume>256</volume>
                <fpage>159</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">9855364</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.kaempfrotzoll.2003.439">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaempf-Rotzoll</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horiguchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashiguchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linderkamp</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Human placental trophoblast cells express alpha-tocopherol transfer protein.</article-title>
                <source>Placenta</source>
                <volume>24</volume>
                <fpage>439</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">12744919</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.kara.2008.471">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kara</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uz&#x000fc;mc&#x000fc;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uyguner</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosti</surname>
                    <given-names>RO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ko&#x000e7;ba&#x0015f;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozmen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kayserili</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Ataxia with vitamin E deficiency associated with deafness.</article-title>
                <source>Turk J Pediatr.</source>
                <year>2008</year>
                <volume>50</volume>
                <fpage>471</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19102053</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.kohlsch_tter.1997.581">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kohlsch&#x000fc;tter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayatepek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finckh</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hubner</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Effect of plasma alpha-tocopherol on leukotriene E4 excretion in genetic vitamin E deficiency.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>20</volume>
                <fpage>581</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9266396</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.larnaout.1997.633">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Larnaout</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zouari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben Hamida</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben Hamida</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Friedreich's ataxia with isolated vitamin E deficiency: a neuropathological study of a Tunisian patient.</article-title>
                <source>Acta Neuropathol (Berl)</source>
                <volume>93</volume>
                <fpage>633</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9194904</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.leonard.2002.555">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terasawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farese</surname>
                    <given-names>RV</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Traber</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Incorporation of deuterated</article-title>
                <source>Am J Clin Nutr</source>
                <volume>75</volume>
                <fpage>555</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">11864863</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.l_pez.2010.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>L&#x000f3;pez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saravia</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoebeke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patarroyo</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Mechanisms of genetically-based resistance to malaria.</article-title>
                <source>Gene</source>
                <volume>467</volume>
                <fpage>1</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">20655368</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.mariotti.2004.130">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mariotti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gellera</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimoldi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mineri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uziel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zorzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pareyson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccolo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gambi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piacentini</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Squitieri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capra</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castellotti</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Donato</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Ataxia with isolated vitamin E deficiency: neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families.</article-title>
                <source>Neurol Sci</source>
                <volume>25</volume>
                <fpage>130</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15300460</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.marzouki.2005.21">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marzouki</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benomar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yahyaoui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birouk</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elouazzani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chkili</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benlemlih</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Vitamin E deficiency ataxia with (744 del A) mutation on alpha-TTP gene: genetic and clinical peculiarities in Moroccan patients.</article-title>
                <source>Eur J Med Genet</source>
                <volume>48</volume>
                <fpage>21</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15953402</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.meier.2003.725">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meier</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomizaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulze-Briese</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumann</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stocker</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>The molecular basis of vitamin E retention: structure of human alpha-tocopherol transfer protein.</article-title>
                <source>J Mol Biol</source>
                <volume>331</volume>
                <fpage>725</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">12899840</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.min.2003.14713">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Min</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kovall</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hendrickson</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Crystal structure of human alpha-tocopherol transfer protein bound to its ligand: implications for ataxia with vitamin E deficiency.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>100</volume>
                <fpage>14713</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14657365</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.morley.2004.4143">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morley</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panagabko</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shineman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mani</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stocker</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atkinson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manor</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Molecular determinants of heritable vitamin E deficiency.</article-title>
                <source>Biochemistry</source>
                <volume>43</volume>
                <fpage>4143</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15065857</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.m_llerschmehl.2004.413">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>M&#x000fc;ller-Schmehl</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beninde</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finckh</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Florian</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dudenhausen</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brigelius-Floh&#x000e9;</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuelke</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Localization of alpha-tocopherol transfer protein in trophoblast, fetal capillaries' endothelium and amnion epithelium of human term placenta.</article-title>
                <source>Free Radic Res.</source>
                <year>2004</year>
                <volume>38</volume>
                <fpage>413</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">15190938</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.ouahchi.1995.141">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ouahchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kayden</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben Hamida</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sokol</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein.</article-title>
                <source>Nat Genet</source>
                <volume>9</volume>
                <fpage>141</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">7719340</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.qian.2006.8236">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Qian</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atkinson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manor</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Biochemical consequences of heritable mutations in the alpha-tocopherol transfer protein.</article-title>
                <source>Biochemistry</source>
                <volume>45</volume>
                <fpage>8236</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">16819822</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.sato.1993.17705">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyata</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tokita</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanabe</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Primary structure of alpha-tocopherol transfer protein from rat liver. Homology with cellular retinaldehyde-binding protein.</article-title>
                <source>J Biol Chem</source>
                <volume>268</volume>
                <fpage>17705</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">8349655</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.schuelke.2000a.1543">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schuelke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elsner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finckh</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlschutter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hubner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brigelius-Flohe</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2000a</year>
                <article-title>Urinary alpha-tocopherol metabolites in alpha-tocopherol transfer protein-deficient patients.</article-title>
                <source>J Lipid Res</source>
                <volume>41</volume>
                <fpage>1543</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">11013295</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.schuelke.2000b.1584">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schuelke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finckh</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sistermans</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ausems</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hubner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Moers</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2000b</year>
                <article-title>Ataxia with vitamin E deficiency: biochemical effects of malcompliance with vitamin E therapy.</article-title>
                <source>Neurology</source>
                <volume>55</volume>
                <fpage>1584</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11094124</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.schuelke.1999.240">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schuelke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayatepek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfeiffer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Speer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hubner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finckh</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Treatment of ataxia in isolated vitamin E deficiency caused by alpha-tocopherol transfer protein deficiency.</article-title>
                <source>J Pediatr</source>
                <volume>134</volume>
                <fpage>240</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">9931538</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.sha.1998.506">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sha</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bankaitis</surname>
                    <given-names>VA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luo</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Crystal structure of the Saccharomyces cerevisiae phosphatidylinositol-transfer protein.</article-title>
                <source>Nature</source>
                <volume>391</volume>
                <fpage>506</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">9461221</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.sharpe.1996.223">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sharpe</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duly</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacAuley</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCrum</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulholland</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stott</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boreham</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trinick</surname>
                    <given-names>TR</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Total radical trapping antioxidant potential (TRAP) and exercise.</article-title>
                <source>QJM</source>
                <volume>89</volume>
                <fpage>223</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8731567</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.shorer.1996.340">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shorer</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parvari</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bril</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sela</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moses</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Ataxia with isolated vitamin E deficiency in four siblings.</article-title>
                <source>Pediatr Neurol</source>
                <volume>15</volume>
                <fpage>340</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">8972536</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.thakur.2010.9339">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thakur</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morley</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manor</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Hepatic &#x003b1;-tocopherol transfer protein: ligand-induced protection from proteasomal degradation.</article-title>
                <source>Biochemistry.</source>
                <volume>49</volume>
                <fpage>9339</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">20828164</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.traber.1990.397">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Traber</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sokol</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burton</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ingold</surname>
                    <given-names>KU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papas</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huffaker</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kayden</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <year>1990</year>
                <article-title>Impaired ability of patients with familial isolated vitamin E deficiency to incorporate alpha-tocopherol into lipoproteins secreted by the liver.</article-title>
                <source>J Clin Invest</source>
                <volume>85</volume>
                <fpage>397</fpage>
                <lpage>407</lpage>
                <pub-id pub-id-type="pmid">2298915</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.traber.1993.201">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Traber</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sokol</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlschutter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokota</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dufour</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kayden</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Impaired discrimination between stereoisomers of alpha-tocopherol in patients with familial isolated vitamin E deficiency.</article-title>
                <source>J Lipid Res</source>
                <volume>34</volume>
                <fpage>201</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">8429255</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.traber.2012.330">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Traber</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manor</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Vitamin E.</article-title>
                <source>Adv Nutr.</source>
                <volume>3</volume>
                <fpage>330</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">22585906</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.ulatowski.2014.120">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ulatowski</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parker</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warrier</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sultana</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butterfield</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manor</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Vitamin E is essential for Purkinje neuron integrity.</article-title>
                <source>Neuroscience</source>
                <volume>260</volume>
                <fpage>120</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24342566</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.usuki.2000.254">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Usuki</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maruyama</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Ataxia caused by mutations in the alpha-tocopherol transfer protein gene.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>69</volume>
                <fpage>254</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10896705</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.weiser.1996.2539">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weiser</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riss</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kormann</surname>
                    <given-names>AW</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Biodiscrimination of the eight alpha-tocopherol stereoisomers results in preferential accumulation of the four 2R forms in tissues and plasma of rats.</article-title>
                <source>J Nutr</source>
                <volume>126</volume>
                <fpage>2539</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">8857515</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.yokota.2000.521">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yokota</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchihara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumagai</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiojiri</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pang</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiyosawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okeda</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizusawa</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Postmortem study of ataxia with retinitis pigmentosa by mutation of the alpha-tocopherol transfer protein gene.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>68</volume>
                <fpage>521</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10727494</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.zimmer.2000.25672">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zimmer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stocker</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarbolouki</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spycher</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sassoon</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azzi</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization.</article-title>
                <source>J Biol Chem</source>
                <volume>275</volume>
                <fpage>25672</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">10829015</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.zortea.2004.275">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zortea</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pastorello</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nunez</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lombardi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonello</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rigoni</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuliani</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mostacciuolo</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gellera</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Donato</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trevisan</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <article-title>Prevalence of inherited ataxias in the province of Padua, Italy.</article-title>
                <source>Neuroepidemiology</source>
                <year>2004</year>
                <volume>23</volume>
                <fpage>275</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">15297793</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="aved.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="aved.Suggested_Reading.reflist0">
            <ref id="aved.REF.christopher_min.2007.23">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Christopher Min</surname>
                    <given-names>K.</given-names>
                  </name>
                </person-group>
                <article-title>Structure and function of alpha-tocopherol transfer protein: implications for vitamin E metabolism and AVED.</article-title>
                <source>Vitam Horm.</source>
                <year>2007</year>
                <volume>76</volume>
                <fpage>23</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">17628170</pub-id>
              </element-citation>
            </ref>
            <ref id="aved.REF.koenig">
              <mixed-citation publication-type="book">Koenig M. Friedreich ataxia and AVED. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID)</italic>. New York, NY: McGraw-Hill. Chap 232. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>.</mixed-citation>
            </ref>
            <ref id="aved.REF.manor.2007.45">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Manor</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morley</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The alpha-tocopherol transfer protein.</article-title>
                <source>Vitam Horm</source>
                <volume>76</volume>
                <fpage>45</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">17628171</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="aved.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="aved.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>13 October 2016 (sw) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>2 November 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>4 September 2007 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>20 May 2005 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>4 October 2004 (ms) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
